These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32366256)

  • 1. IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis.
    Desu HL; Plastini M; Illiano P; Bramlett HM; Dietrich WD; de Rivero Vaccari JP; Brambilla R; Keane RW
    J Neuroinflammation; 2020 May; 17(1):143. PubMed ID: 32366256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice.
    Yuan H; Chen S; Duncan MR; de Rivero Vaccari JP; Keane RW; Dalton Dietrich W; Chou TH; Benny M; Schmidt AF; Young K; Park KK; Porciatti V; Elizabeth Hartnett M; Wu S
    Angiogenesis; 2024 Aug; 27(3):423-440. PubMed ID: 38709389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
    Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
    Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis.
    Shaw PJ; Lukens JR; Burns S; Chi H; McGargill MA; Kanneganti TD
    J Immunol; 2010 May; 184(9):4610-4. PubMed ID: 20368281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation.
    Mei F; Guo S; He Y; Wang L; Wang H; Niu J; Kong J; Li X; Wu Y; Xiao L
    PLoS One; 2012; 7(8):e42746. PubMed ID: 22912731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
    Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
    Front Immunol; 2021; 12():792465. PubMed ID: 34975892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.
    Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Fakour M; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Tashakori-Miyanroudi M; Roghani M
    J Mol Neurosci; 2021 Feb; 71(2):215-224. PubMed ID: 32812186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord.
    Chechneva OV; Mayrhofer F; Daugherty DJ; Pleasure DE; Hong JS; Deng W
    Neurobiol Dis; 2011 Oct; 44(1):63-72. PubMed ID: 21704706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
    J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophils are dispensable for development of MOG
    Ruppova K; Lim JH; Fodelianaki G; August A; Neuwirth A
    Immunol Lett; 2021 Nov; 239():72-76. PubMed ID: 34499922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
    Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
    Front Immunol; 2020; 11():575451. PubMed ID: 33329540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRID3, a blocker of apoptosis associated speck like protein containing a card, ameliorates murine spinal cord injury by improving local immune microenvironment.
    Chen YQ; Wang SN; Shi YJ; Chen J; Ding SQ; Tang J; Shen L; Wang R; Ding H; Hu JG; Lü HZ
    J Neuroinflammation; 2020 Aug; 17(1):255. PubMed ID: 32861243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
    Zhang D; Qiao L; Fu T
    Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 Ameliorates Autoimmune Neuroinflammation by Modulating the Balance of T Helper 17 Cells and Regulatory T Cells in Mouse.
    Li J; Zhang Z; Du S; Guo Q
    Ann Clin Lab Sci; 2021 Jul; 51(4):529-534. PubMed ID: 34452891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
    Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
    Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.
    Nichols JM; Kummari E; Sherman J; Yang EJ; Dhital S; Gilfeather C; Yray G; Morgan T; Kaplan BLF
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):346-362. PubMed ID: 32440886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107.
    Mizrachi T; Marsha O; Brusin K; Ben-David Y; Thakur GA; Vaknin-Dembinsky A; Treinin M; Brenner T
    J Neuroinflammation; 2021 Apr; 18(1):99. PubMed ID: 33902624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.